Vertebro-basilar occlusive disease

1. Taylor, J.
2. Brizuela, J. A.
3. Merino Díaz, Borja
4. Gastambide, María Victoria
5. Estévez, I.
6. Fuente, R.
7. Vaquero Puerta, Carlos

Exportar

Exportar

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Exportar

×

El documento no se puede exportar porque pertenece a otro portal.

Texto completo

lock_openTexto completo externo

DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Revista española de investigaciones quirúrgicas

Resumen

Vertebro-basilar occlusive disease is a condition that can cause symptomatology related to encephalic posterior circulation ischemia. Vertebro-basilar (VB) ischemia represents a 25% of all TIA�s and Strokes in North America (1). In a patient with a VB-TIA, if vertebro-basilar (VB) pathology is demonstrated, he or she will have a 30-35% risk of having a VB circulation stroke in the next 5 years (2); demonstrating that vertebro-basilar occlusive disease is a relevant condition regarding mortality, morbidity and health-related costs. Since Crawford and colleagues described the trans-subclavian vertebral artery endarterectomy by the end of the 50�s, vertebro-basilar occlusive disease has been studied rather little. We pretend to do a revision of this disease, and to discuss briefly the most up-to-date therapies described in current literature for this condition.

Fuente de los datos: Dialnet